<DOC>
	<DOCNO>NCT02074774</DOCNO>
	<brief_summary>The overall objective study demonstrate IntellO2 device provide automate control fraction inspire oxygen ( FiO2 ) adjustments spontaneously breathing infant fluctuate arterial blood oxygen saturation level safe efficacious routine clinical environment . Specifically , hypothesize IntellO2 perform well well standard practice maintain infant ' arterial blood oxygen saturation target range minimize exposure elevate level oxygen inspire gas .</brief_summary>
	<brief_title>IntellO2 vs Manual Control Optimizing Oxygenation Infants</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<criteria>1 . Preterm infant treat high flow nasal cannula therapy 2 . A need supplemental oxygen demonstrate require FiO2 &gt; 0.25 enrollment 3 . Requiring flow rate great 2 L/min assume inspired oxygen fraction match deliver oxygen fraction ( definition HFNC ) . 1 . Major congenital abnormality 2 . Hemodynamic instability , define outside normotensive range base infant 's individual characteristic 3 . Seizures 4 . Ongoing sepsis 5 . Meningitis 6 . Clinician 's concern regard stability infant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>nasal cannula , high flow oxygen therapy , pulse oximetry</keyword>
</DOC>